SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aevi Genomic Medicine, LLC – ‘15-12B’ on 2/14/20

On:  Friday, 2/14/20, at 10:57am ET   ·   Effective:  2/14/20   ·   Accession #:  1104659-20-21056   ·   File #:  1-35112

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/20  Aevi Genomic Medicine, LLC        15-12B      2/14/20    1:12K                                    Toppan Merrill/FA

Certification of Termination of Registration of a Class of Securities   —   Form 15   —   Sect. 12(b) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 15-12B      Certification of Termination of Registration of a   HTML      9K 
                Class of Securities                                              


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 001-35112

 

Aevi Genomic Medicine, LLC

(Exact name of registrant as specified in its charter)

 

435 Devon Park Drive, Suite 715

Wayne, Pennsylvania 19087

 

(610) 254-4201

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.0001 par value per share

(Title of each class of securities covered by this Form)

 

None

(Title of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

    Rule 12g-4(a)(1)   x
    Rule 12g-4(a)(2)   ¨
    Rule 12h-3(b)(1)(i)   x
    Rule 12h-3(b)(1)(ii)   ¨
    Rule 15d-6   ¨
    Rule 15d-22(b)   ¨

 

Approximate number of holders of record as of the certification or notice date: One

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Aevi Genomic Medicine, LLC has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: February 14, 2020   Aevi Genomic Medicine, LLC
     
    By:  

/s/ Michael F. Cola

    Name:     Michael F. Cola
    Title:   Vice President

 

 C: 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘15-12B’ Filing    Date    Other Filings
Filed on / Effective on:2/14/20EFFECT,  SC 13G/A
 List all Filings 
Top
Filing Submission 0001104659-20-021056   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 7:01:12.1am ET